Skip to main content
Top

Inflammation Research

Issue 10/2014

Content (9 Articles)

Short Communication

Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study

Elçin Şehitoğlu, Filiz Çavuş, Canan Ulusoy, Melike Küçükerden, Arda Örçen, Deniz Akbaş-Demir, Arzu Çoban, Burçak Vural, Erdem Tüzün, Recai Türkoğlu

Open Access Review

Inflammation and vitamin D: the infection connection

Meg Mangin, Rebecca Sinha, Kelly Fincher

Original Research Paper

NLRP3 inflammasome activation and interleukin-1β release in macrophages require calcium but are independent of calcium-activated NADPH oxidases

Balázs Rada, Jonathan J. Park, Payel Sil, Miklós Geiszt, Thomas L. Leto

Original Research Paper

Albumin and glycated albumin activate KIM-1 release in tubular epithelial cells through distinct kinetics and mechanisms

Ai Ing Lim, Loretta Y. Y. Chan, Sydney C. W. Tang, Kar Neng Lai, Joseph C. K. Leung

Original Research Paper

Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients

Alessandro Baldan, Silvia Ferronato, Silvia Olivato, Giovanni Malerba, Alberto Scuro, Gian Franco Veraldi, Matteo Gelati, Sergio Ferrari, Sara Mariotto, Pier Franco Pignatti, Sara Mazzucco, Macarena Gomez-Lira

Original Research Paper

Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features

Fabio J. Pacheco, Frankis G. Almaguel, Whitney Evans, Leslimar Rios-Colon, Valery Filippov, Lai S. Leoh, Elizabeth Rook-Arena, Melanie Mediavilla-Varela, Marino De Leon, Carlos A. Casiano

Original Research Paper

Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins

Weston Spivia, Patrick S. Magno, Patrick Le, Deborah A. Fraser

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine